DE518215C - Process for obtaining all of the oxyanthraquinone derivatives in the free state from corresponding drugs - Google Patents
Process for obtaining all of the oxyanthraquinone derivatives in the free state from corresponding drugsInfo
- Publication number
- DE518215C DE518215C DEST45395D DEST045395D DE518215C DE 518215 C DE518215 C DE 518215C DE ST45395 D DEST45395 D DE ST45395D DE ST045395 D DEST045395 D DE ST045395D DE 518215 C DE518215 C DE 518215C
- Authority
- DE
- Germany
- Prior art keywords
- oxyanthraquinone
- derivatives
- obtaining
- free state
- corresponding drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
- C07C46/10—Separation; Purification; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Description
Verfahren zur Gewinnung der gesamten Oxyanthrachinonderivate in freiem Zustande aus entsprechenden Drogen Die Oxyanthrachinonderivate, wie Emodin usw., sind in den entsprechenden Drogen teils in freier, teils in gebundener Form enthalten. Die freien Substanzen sind in organischen Lösungsmitteln, wie Äther und chlorierten Iohlenwasserstoffen, z. B. Chloroform, Trichloräthylen usw., gut löslich, die gebundenen dagegen in diesen Lösungsmitteln unlöslich. Erschöpft man zum Beispiel in einem geeigneten Extraktionsapparate trockene Rinde @-on Rharnus frangulae mit trockenem Äther. so erhält man bis zur vollständigen Erschöpfung insgesamt q.,2°/" freie Oxyanthrachinone. Wird dagegen die Rinde vor der Extraktion mit Äther mit 2°/oiger Schwefelsäure behandelt, danach die Schwefelsäure neutralisiert und die Rinde wieder getrocknet, so erhält man bei der Extraktion mit trockenem Äther nunmehr i i,o8 °lQ. Die Droge enthält also i i,o8°f0- 4,2°0 - 6,88 °J" Oxyanthrachinone in gebundener Form.Process for obtaining all of the oxyanthraquinone derivatives in the free state from corresponding drugs The oxyanthraquinone derivatives, such as emodin, etc., are contained in the corresponding drugs partly in free, partly in bound form. The free substances are in organic solvents such as ethers and chlorinated hydrocarbons, e.g. B. chloroform, trichlorethylene, etc., readily soluble, the bound, however, insoluble in these solvents. For example, one exhausts dry bark @ -on Rharnus frangulae with dry ether in a suitable extraction apparatus. Thus a total of q.2% of free oxyanthraquinones is obtained up to complete exhaustion. If, on the other hand, the bark is treated with ether with 2% sulfuric acid before the extraction, then the sulfuric acid is neutralized and the bark is dried again, one obtains with the Extraction with dry ether is now 10.8 ° 1Q. The drug thus contains 10.8 ° F0-4.2 ° 0 - 6.88 ° J "oxyanthraquinones in bound form.
Es hat sich nun gezeigt, daß die Spaltung auch ohne Säurebehandlung allein schon durch Wasser erfolgt, und daß dazu selbst die Benutzung eines wassergesättigten, organischen Extraktionsmittels ausreicht.It has now been shown that the cleavage takes place even without acid treatment is done by water alone, and that even the use of a water-saturated, organic extractant is sufficient.
B e i s p i e 1. In einem Soxhletschen Extraktionsapparat werden i o g Droge, z. B. Cortex frangulae, in -der Weise Extrahiert, daß in dem den Äther enthaltenden unteren Sammelgefäß eine Bodenschicht von Wasser enthalten ist, etwa im Verhältnis von 5 Volumprozent des zu verwendenden Äthers. Extrahiert man auf diese Weise die Cortex frangulae, so gewinnt man in einem Arbeitsgang io,9 0`o Oxyanthrachinone in fast reiner Form ohne merkliche Verunreinigung mit den wasserlöslichen Beistoffen, wie Zucker, Gerbstoff, fremde Säuren usw. In gleicher Weise läßt sich statt Äther ein anderes mit Wasser wenig mischbares, organisches Extraktionsmittel verwenden, wie z. B. gechlorte Ilohlenwasserstoffe (Chloroform, Trichloräthylen usw.l.EXAMPLE 1. In a Soxhlet extraction apparatus i o g drug, e.g. B. Cortex frangulae, extracted in such a way that in which the ether containing lower collecting vessel contains a bottom layer of water, for example in the ratio of 5 percent by volume of the ether to be used. One extracts on In this way, the cortex frangulae, one obtains 10.9 0`o oxyanthraquinones in one operation in almost pure form without noticeable contamination with the water-soluble co-formulants, like sugar, tannin, foreign acids, etc. In the same way, instead of ether use another organic extractant that is difficult to mix with water, such as B. chlorinated hydrocarbons (chloroform, trichlorethylene, etc.)
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEST45395D DE518215C (en) | 1929-02-06 | 1929-02-06 | Process for obtaining all of the oxyanthraquinone derivatives in the free state from corresponding drugs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEST45395D DE518215C (en) | 1929-02-06 | 1929-02-06 | Process for obtaining all of the oxyanthraquinone derivatives in the free state from corresponding drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
DE518215C true DE518215C (en) | 1931-02-13 |
Family
ID=7464884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DEST45395D Expired DE518215C (en) | 1929-02-06 | 1929-02-06 | Process for obtaining all of the oxyanthraquinone derivatives in the free state from corresponding drugs |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE518215C (en) |
-
1929
- 1929-02-06 DE DEST45395D patent/DE518215C/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE518215C (en) | Process for obtaining all of the oxyanthraquinone derivatives in the free state from corresponding drugs | |
DE523144C (en) | Process for the production of water-rich cholesterol solutions | |
DE531828C (en) | Process for debittering lupins | |
DE469256C (en) | Process for making goods mothproof | |
DE606009C (en) | Process for the production of conversion products of the polysaccharides | |
DE544031C (en) | Process for the complete breakdown of the cell tissue of plants or plant parts for the purpose of obtaining pectin substances | |
DE371541C (en) | Method for removing impregnation compounds from plant tissues | |
DE830195C (en) | Process for the production of highly effective ergot alkaloid extracts | |
DE626469C (en) | Process for the production of high-quality, odorless, iodine-containing allium preparations | |
DE528921C (en) | Process for the production of a preparation from Cassia fistula for therapeutic purposes | |
DE531046C (en) | Process for the production of pectin | |
DE344499C (en) | Process for the regeneration of used bleaching earth | |
DE953644C (en) | Method of making a medicinal product | |
AT117228B (en) | Process for the preparation of organ specimens by extraction. | |
DE814670C (en) | Process for the production of a long-life solution of guaiacol for the detection of high heating of milk and milk products | |
DE525946C (en) | Process for the extraction of acid-free oils and fats | |
AT117679B (en) | Process for obtaining the active bases of ergot. | |
DE491573C (en) | Process for obtaining durable filicin solutions | |
DE826752C (en) | Process for the production of surface-active substances which contain silica | |
DE435530C (en) | Process for obtaining a therapeutically active substance | |
DE539289C (en) | Process for the production of highly effective, debittered anthranyl glucoside-containing extracts from anthraquinone-containing drugs | |
DE612416C (en) | Process for the preservation of acidyl celluloses | |
DE523938C (en) | Process for cleaning and discoloring rosin | |
DE469094C (en) | Method of protection against moth damage | |
DE693299C (en) | Process for the manufacture of a medicament |